Cargando…
Outcomes of single dose COVID-19 vaccines: Eight month follow-up of a large cohort in Saudi Arabia
BACKGROUND: Two vaccines for COVID-19 have been approved and administered in the Kingdom of Saudi Arabia (KSA); Pfizer-BioNtech BNT162b2 and AstraZeneca-Oxford AZD1222 vaccines. The purpose of this study was to describe the real-world data on the outcome of single dose of these COVID-19 vaccines in...
Autores principales: | Alharbi, Naif Khalaf, Al-Tawfiq, Jaffar A., Alghnam, Suliman, Alwehaibe, Amal, Alasmari, Abrar, Alsagaby, Suliman A., Alsubaie, Faisal, Alshomrani, Majid, Farahat, Fayssal M., Bosaeed, Mohammad, Alharbi, Ahmad, Aldibasi, Omar, Assiri, Abdullah M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd on behalf of King Saud Bin Abdulaziz University for Health Sciences.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986276/ https://www.ncbi.nlm.nih.gov/pubmed/35472755 http://dx.doi.org/10.1016/j.jiph.2022.04.001 |
Ejemplares similares
-
Persistence of Anti-SARS-CoV-2 Spike IgG Antibodies Following COVID-19 Vaccines
por: Alharbi, Naif Khalaf, et al.
Publicado: (2022) -
Risk factors of SARS-CoV-2 infection in cancer patients pre- and post-vaccination
por: Alsagaby, Suliman A., et al.
Publicado: (2022) -
Comparison of Hospital Readmission and Mortality between COVID-19 and Pneumonia Patients
por: Alyabsi, Mesnad, et al.
Publicado: (2022) -
COVID-19 reinfection: A multicenter retrospective study in Saudi Arabia
por: Shaheen, Naila A., et al.
Publicado: (2022) -
Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia
por: Abolfotouh, Mostafa A., et al.
Publicado: (2022)